Skip to main content

ARCT

Stock

ARCT

Stock
Health Care
Biotechnology

Performance overview

ARCT Price
Price Chart

Forward-looking statistics

Beta
1.26
Risk
73.58%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.

Company info

SectorHealth Care
IndustryBiotechnology
Employees182
Market cap$857.0M

Fundamentals

Enterprise value$178.5M
Revenue$143.7M
Revenue per employee—
Profit margin-47.47%
Debt to equity18.25

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$2.52
Dividend per share—
Revenue per share$5.31
Avg trading volume (30 day)$7M
Avg trading volume (10 day)$7M
Put-call ratio—

Macro factor sensitivity

Growth+0.7
Credit+6.9
Liquidity-1.5
Inflation-4.1
Commodities-0.0
Interest Rates-1.2

Valuation

Dividend yield0.00%
PEG Ratio-6.18
Price to sales2.60
P/E Ratio-6.18
Enterprise Value to Revenue1.24
Price to book1.60

Upcoming events

Next earnings dayAugust 4, 2025
Next dividend day—
Ex. dividend day—

News

Wall Street Analysts Think Arcturus Therapeutics (ARCT) Could Surge 371.35%: Read This Before Placing a Bet

The mean of analysts' price targets for Arcturus Therapeutics (ARCT) points to a 371.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Zacks Investment Research (June 3, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free